Fresenius Ventures

Germany

Series A

About Fresenius Ventures

Fresenius has launched Fresenius Ventures, its corporate VC unit, deploying over 200 million euros over five years into healthcare adjacencies to its pharma, medtech and care-provision platforms: precision nutrition, microbiome research, new therapeutic modalities and digital care. Funded on-balance-sheet, led by ex-Angelini Ventures investor Thomas Thestrup.

Investment Focus

Location / RegionGermany

Funding StageSeries A

Industry Focus

Biotech

Digital Health

Investor Signals Profile

active

Sweet Spot

Healthcare-adjacency founder, EU-based, open to strategic corporate investor

corporate venture capital

healthcare adjacencies

precision nutrition

microbiome

digital care

Bullish Signals

EUR200M+ committed on-balance-sheet over 5 yearsexternal

Framed as core to FutureFresenius strategyexternal

Contrarian Signals

No contrarian signals recorded.

Founder Do's

Build healthcare adjacency to pharma/medtech/care

Open to strategic corporate investor

EU relevance required

Founder Don'ts

Expect fast financial-VC decision cycles

Key GPs & Partners

Thomas Michael Thestrup

Managing Director & Head

corporate-VCscientist-dealmaker

Unlock Investor Signals

€29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€2.0K

Saves0

Key People

Thomas Michael Thestrup

Thomas Michael ThestrupManaging Director & Head

Related Funds

Realyze Ventures (Proptech Fund)

€57.6M

Germany

Seed

Saas

Fund Manager:Manfred Heid, Kai Anitzki, Stefan Läufer

Seed

Saas

KfW Capital (Impact Facility)

€200M

Germany

Pre Seed

Ai Ml, Climate Sustainability

Fund Manager:Co, Jörg Goschin

Pre Seed

Ai Ml

Climate Sustainability

DTCP European Defence VC Fund

€500M

Germany

Seed

Defense, Space, Cybersecurity, Ai Ml, Manufacturing

Fund Manager:Thomas Preuss, Philipp von Bismarck, Jack J. Young

Seed

Defense

Space

Cybersecurity

Ai Ml

Manufacturing